About this trial
The purpose of this study is to explore the efficacy and safety of remote ischemic conditioning for essential hypertension in the community population.
Eligibility criteria
Qualifiers
Age≥30 years, ≤ 75 years, regardless of sex;
Patients with a history of essential hypertension and systolic blood pressure (SBP) ≥140 mmHg in three blood pressure measurements performed on separate days within 3 days prior to enrollment.
Signed and dated informed consent is obtained.
Disqualifiers
Blood pressure ≥ 180/110mmHg;
Planned adjustment of antihypertensive drugs within the next 3 weeks;
Severe hematologic disorders or significant coagulation abnormalities;
Individuals who had contraindication of remote ischemic conditioning, such as severe soft tissue injury, fracture or vascular injury in the upper limb, acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc;
Trial design
Treatments tested in this trial
- Patients are treated with previous antihypertensive treatment plus remote ischemic conditioning.
- Previous antihypertensive treatment
Treatment groups
Sponsors and collaborators
Yi Yang
Lead sponsor
The First Hospital of Jilin University
Sponsor institution